Skip to content
Back to the collection

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

Jiansong Fang, Pengyue Zhang, Yadi Zhou

Show all 11 authors

Chien-Wei Chiang, Juan Tan, Yuan Hou, Shaun Stauffer, Lang Li, Andrew A. Pieper, Jeffrey Cummings, Feixiong Cheng

2021 · Nature Aging

Read the paper
HN score
0
Mentions
3
Readers
3
Months
3
What’s in a score?

In the conversation

Original HN comments, with labels from simple text rules. A label describes the whole comment and may miss context or irony. Read the discussion to make up your own mind. About the labels

3 selected excerpts · 3 total mentions

sbierwagen
Neutral mention · rule
Blogspam. Nature article: https://www.nature.com/articles/s43587-021-00138-z >Based on retrospective case–control pharmacoepidemiologic analyses of insurance claims data for 7.23 million individuals, we found that sildenafil usage was significantly associated with a 69% reduced risk of AD (hazard ratio 0.31, 95% confidence interval 0.25–0.39, P < 1.0 × 10^–8). Retrospective study, so no causation proved, of course. That will require an actual randomized clinical trial, which hasn't been done.
cheald
Neutral mention · rule
Cialis has been linked to mitigation of cognitive decline: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705107/ https://www.nature.com/articles/s41598-019-53136-y And Viagra has been identified as a potential tool against Alzhimers: https://www.nature.com/articles/s43587-021-00138-z https://content.iospress.com/articles/journal-of-alzheimers-... Ideally, we'd identify the key mechanisms at play and be able to develop lifestyle modifications that would support them, but it's pretty cool that these drugs have benefits beyond just better bedroom performance.

Keep following the thread.

More in Biology & medicine

More from the same topics.